V2X, Inc.

VVX

CIK 0001601548 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1.22B
↑+5.3% +$61Mvs FY2024 (Q4)
Operating Income
$51M
↓-0.4% -$197Kvs FY2024 (Q4)
Net Income
$23M
↑+18.0% +$3Mvs FY2024 (Q4)
Gross Profit
$105M
↓-2.2% -$2Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
47/100
  • Profitability
    10ROIC 7.0% (10% = solid, 20%+ = moat)
  • Liquidity
    36Current Ratio 1.22 (above 1.5 = solid)
  • Leverage
    50D/E 1.00 (under 0.5 = conservative)
  • Efficiency
    90Asset Turnover 1.38x (1.0+ = capital-efficient)
  • Growth
    34Revenue YoY +5.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    61Op Margin 4.2% · trend +0.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project VVX's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 28.0%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$178.27
Total enterprise IV
$5.67B
Diluted shares
0.03B
Terminal PV
$4.40B (78% of total)
Year-5 FCF
$519M
YearProjected FCFDiscounted PV
+1$213M$193M
+2$266M$220M
+3$332M$250M
+4$415M$284M
+5$519M$322M
Terminal$7.09B$4.40B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$12M
investment in PP&E
Stock buybacks (TTM)
$30M
share count reduction
Stock-based comp (TTM)
$12M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$3.28B
everything owned
Total liabilities
$2.20B
everything owed
Stockholders' equity
$1.08B
shareholder claim
Net debt
$1.01B
LT debt minus cash

Recent performance · 56 quarters

Revenue↑+5.3% +$61M
$1.22B
Net Income↑+16.0% +$3M
$23M
Free Cash Flow↓-6.7% -$15M
$207M
Operating Margin↓-0.2pts
4.2%

Drill down